9th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, 19-21 July 2007, Sydney
3 September 2007. Related: Conference reports.
Lipodystrophy Workshop (IWADRW) 9th Sydney 2007
Can nevirapine be safely substituted for other agents in those with high CD4 cell counts and virologic suppression?
3 September 2007. Related: Conference reports.
Do children with perinatally acquired HIV infection have problems with metabolism and body shape?
3 September 2007. Related: Conference reports.
The growth hormone releasing factor analogue tesamorelin (TH9507) reduces visceral fat, but what else does it do?
3 September 2007. Related: Conference reports.
Does diabetes have the same impact on cardiovascular risk in HIV-positive patients as it does in the general population?
3 September 2007. Related: Conference reports.
Can nucleoside RT inhibitors directly cause insulin resistance?
3 September 2007. Related: Conference reports.
Do dyslipidemia, insulin resistance, and body shape changes differ according to race or ethnicity?
3 September 2007. Related: Conference reports.
Is lipoatrophy associated with vascular dysfunction?
3 September 2007. Related: Conference reports.